Clinical Trial Update: Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study) [Phase 4]

View source ↗

Summary

This Phase 4 pharmacokinetic study evaluated optimal dosing of first-line tuberculosis and antiretroviral drugs in children and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Snippet

Sponsor: University of Cape Town | Conditions: Tuberculosis, HIV | Phase 4 | Status: COMPLETED